심장 부정맥 모니터링 기기 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별

Cardiac Arrhythmia Monitoring Devices Market, By Product Type, By Application, By End User,, By Geography

US $ 4,500 ￦ 6,535,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 10,166,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,524,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

심장 부정맥 모니터링 기기 시장은 2025년에 94억 4,000만 달러, 2032년에는 159억 7,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 7.8%를 나타낼 전망입니다.

보고서 범위		보고서 상세
기준 연도	2024	2025년 시장 규모	94억 4,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간(2025-2032년) CAGR	7.80%	2032년 가치 예측	159억 7,000만 달러

부정맥이라고도 알려진 심장 부정맥은 전 세계적으로 수백만 명이 앓고 있는 흔한 심혈관계 질환입니다. 부정맥은 심장의 비정상적인 전기적 신호가 특징이며, 효과적으로 모니터링하고 관리하지 않으면 다양한 합병증을 유발할 수 있습니다. 최근 부정맥의 진단과 추적을 돕고 적시에 개입하여 환자의 예후를 개선할 수 있는 심장 부정맥 모니터링 장비에 대한 수요가 증가하고 있습니다.

시장 역학:

세계 심장 부정맥 모니터링 장치 시장은 향후 몇 년 동안 큰 성장을 이룰 것으로 예측됩니다. 심혈관 질환의 유병률 증가, 심장 건강에 대한 인식 증가, 의료 기술의 발전 등 여러 가지 요인이 이러한 성장을 가속하고 있습니다. 또한, 심장 부정맥에 취약한 노인 인구 증가도 시장 확대에 기여하고 있습니다.

시장 기업들은 규제 당국의 제품 승인을 받기 위해 노력하고 있으며, 이는 예측 기간 동안 세계 심장 부정맥 모니터링 장치 시장의 성장을 증가시킬 것으로 예측됩니다. 예를 들어, 맞춤형 심장 진단 및 모니터링 솔루션 제공업체인 Global Instrumentation LLC는 2021년 1월 10일 미국 식품의약국(FDA)의 승인을 받은 M5 웨어러블 ECG 레코더의 CE 마크 인증을 획득했습니다. 레코더에 대한 CE 마크 인증을 획득했습니다.

그러나 시장은 몇 가지 억제요인에 직면해 있습니다. 그 중 하나는 이러한 기기의 높은 비용으로 인해 저소득 지역의 환자들에게 접근하기 어렵다는 점입니다. 또한, 이러한 기기의 데이터를 효과적으로 사용하고 해석할 수 있는 숙련된 의료 전문가가 부족하다는 점도 시장 성장에 걸림돌로 작용하고 있습니다.

이러한 도전에도 불구하고, 시장 기업이 활용할 수 있는 기회는 충분합니다. 인공지능 및 머신러닝 알고리즘의 통합과 같은 기술 발전은 보다 정확하고 효율적인 모니터링 장비의 개발을 가능하게 하고 있습니다. 또한, 원격 의료 및 원격 환자 모니터링 솔루션의 채택이 증가하고 있으며, 이는 시장에 새로운 길을 열어주고 있습니다.

본 조사의 주요 특징

• 본 보고서는 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모와 연평균 성장률(CAGR)을 포함한 세계 심장 부정맥 모니터링 장치 시장을 상세하게 분석하였습니다.
• 이 보고서는 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 주요 조사 대상 기업은 Medtronic, Abbott Laboratories, Boston Scientific, Biotronic, Koninklijke Philips, Nippon Photonics, Fukuda Electronics, Hylom Holdings, Mindray Medical, Schiller AG, Spacelabs Healthcare, GE Healthcare, Cardiac Science Corporation, Lifewatch AG, Beijing Choice Electronic Tech Co. Spacelabs Healthcare,GE Healthcare,Cardiac Science Corporation,Lifewatch AG,Beijing Choice Electronic Tech Co,Vivaquant,Preventice Solutions, iRhythm Technologies,Applied Cardiovascular Technologies,Applied Cardiovascular Solutions iRhythm Technologies, Applied Cardiac Systems, BioTelemetry 등입니다.
• 이 보고서의 통찰력을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 심장 부정맥 모니터링 장치 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 심장 부정맥 모니터링 장치 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매/승인
• PEST 분석
• PORTER 분석
• 인수합병(M&A) 시나리오

제4장 심장 부정맥 모니터링 기기 시장, 제품 유형별, 2020년-2032년

• 안정시 심전도 장비
• ECG 스트레스 테스트 장비
• 모바일 심장 텔레메트리 모니터
• 이식형 심장 모니터
• 홀터 모니터
• 이벤트 모니터
• 기타(웨어러블 심전도 모니터, 스마트 심전도 모니터)

제5장 심장 부정맥 모니터링 기기 시장, 용도별, 2020년-2032년

• 서맥
• 빈맥
• 심방세동
• 기외 수축
• 전도 장애
• 기타(심실세동, 페이싱 모니터링)

제6장 심장 부정맥 모니터링 기기 시장, 최종사용자별, 2020년-2032년

• 병원
• 진단센터
• 외래수술센터(ASC)
• 홈케어 환경
• 기타(연구기관, 전문 클리닉)

제7장 심장 부정맥 모니터링 기기 시장, 지역별, 2020년-2032년

• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 중동
  • GCC
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙아프리카

제8장 경쟁 구도

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Biotronik
• Koninklijke Philips
• Nihon Kohden
• Fukuda Denshi
• Hill-Rom Holdings
• Mindray Medical
• Schiller AG
• Spacelabs Healthcare
• GE Healthcare
• Cardiac Science Corporation
• Lifewatch AG
• Beijing Choice Electronic Tech Co
• Vivaquant
• Preventice Solutions
• iRhythm Technologies
• Applied Cardiac Systems
• BioTelemetry

제9장 섹션

• 조사 방법
• 출판사에 대해

LSH

영문 목차

영문목차

Cardiac Arrhythmia Monitoring Devices Market is estimated to be valued at USD 9.44 Bn in 2025 and is expected to reach USD 15.97 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 9.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.80%	2032 Value Projection:	USD 15.97 Bn

Cardiac arrhythmia, also known as an irregular heartbeat, is a common cardiovascular condition that affects millions of people worldwide. It is characterized by abnormal electrical signals in the heart, which can lead to various complications if not monitored and managed effectively. In recent years, there has been a growing demand for cardiac arrhythmia monitoring devices that can help diagnose and track the condition, thereby enabling timely interventions and improving patient outcomes.

Market Dynamics:

The global cardiac arrhythmia monitoring devices market is set to experience significant growth in the coming years. Several factors are driving this growth, including the rising prevalence of cardiovascular diseases, increasing awareness about heart health, and advancements in medical technology. Moreover, the growing geriatric population, which is more susceptible to cardiac arrhythmias, is also contributing to the market's expansion.

Market players are engaged in receiving approval from the regulatory authorities for their products, and this is expected to increase the growth of the global cardiac arrhythmia monitoring devices market over the forecast period. For instance, on January 10, 2022, Global Instrumentation LLC, a provider of customized cardiac diagnostic and monitoring solutions, received the CE Mark certification for the M5 wearable ECG recorder that had earlier been approved by the U.S. Food and Drug Administration (U.S. FDA) authority in January 2021.

However, the market does face some restraints. One such restraint is the high cost associated with these devices, making them less accessible to patients in low-income regions. Additionally, the lack of skilled healthcare professionals who can effectively use and interpret the data from these devices poses a challenge to the market's growth.

Despite these challenges, there are ample opportunities for market players to capitalize on. Technological advancements, like the integration of artificial intelligence and machine learning algorithms, are enabling the development of more accurate and efficient monitoring devices. Furthermore, the increasing adoption of telemedicine and remote patient monitoring solutions is opening up new avenues for the market.

Key features of the study:

• This report provides in-depth analysis of the global cardiac arrhythmia monitoring devices market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period of 2025-2032, with 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key companies covered in this study include Medtronic, Abbott Laboratories, Boston Scientific, Biotronik, Koninklijke Philips, Nihon Kohden, Fukuda Denshi, Hill-Rom Holdings, Mindray Medical, Schiller AG, Spacelabs Healthcare, GE Healthcare, Cardiac Science Corporation, Lifewatch AG, Beijing Choice Electronic Tech Co, Vivaquant, Preventice Solutions, iRhythm Technologies, Applied Cardiac Systems, and BioTelemetry
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product upgrades, market expansion, and marketing tactics
• The global cardiac arrhythmia monitoring devices market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac arrhythmia monitoring devices market

Global Cardiac Arrhythmia Monitoring Devices Market Segmentation:

• By Product Type
  • Resting ECG Devices
  • ECG Stress Test Devices
  • Mobile Cardiac Telemetry Monitors
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Event Monitors
  • Others (Wearable ECG Monitors, Smart ECG Monitors)
• By Application
  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Premature Contraction
  • Conduction Disorders
  • Others (Ventricular Fibrillation, Pacing Monitoring)
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others (Research Institutes, Specialty Clinics)
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top companies in Global Cardiac Arrhythmia Monitoring Devices Market:
  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Biotronik
  • Koninklijke Philips
  • Nihon Kohden
  • Fukuda Denshi
  • Hill-Rom Holdings
  • Mindray Medical
  • Schiller AG
  • Spacelabs Healthcare
  • GE Healthcare
  • Cardiac Science Corporation
  • Lifewatch AG
  • Beijing Choice Electronic Tech Co
  • Vivaquant
  • Preventice Solutions
  • iRhythm Technologies
  • Applied Cardiac Systems
  • BioTelemetry

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Cardiac Arrhythmia Monitoring Devices, By Product Type
  • Market Cardiac Arrhythmia Monitoring Devices, By Application
  • Market Cardiac Arrhythmia Monitoring Devices, By End User
  • Market Cardiac Arrhythmia Monitoring Devices, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• The rising prevalence of cardiovascular diseases
  • Restraints
• The lack of skilled healthcare professionals
  • Opportunities
• Technological advancements, like the integration of artificial intelligence and machine learning algorithms
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Cardiac Arrhythmia Monitoring Devices Market , By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Resting ECG Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• ECG Stress Test Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Mobile Cardiac Telemetry Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Implantable Cardiac Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Holter Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Event Monitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Wearable ECG Monitors, Smart ECG Monitors)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

5. Cardiac Arrhythmia Monitoring Devices Market , By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Bradycardia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tachycardia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Atrial Fibrillation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Premature Contraction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Conduction Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Ventricular Fibrillation, Pacing Monitoring)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Cardiac Arrhythmia Monitoring Devices Market , By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Research Institutes, Specialty Clinics)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Cardiac Arrhythmia Monitoring Devices Market , By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boston Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotronik
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nihon Kohden
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fukuda Denshi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hill-Rom Holdings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mindray Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Schiller AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Spacelabs Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardiac Science Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lifewatch AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Beijing Choice Electronic Tech Co
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vivaquant
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Preventice Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• iRhythm Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Applied Cardiac Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioTelemetry
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us

관련자료